Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua J Meeks

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
European Urology Focus|December 5, 2025
Urothelial Cancer: What Is the Role of Expression-based Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive Bladder Cancer?Joshua J Meeks
Urology|April 24, 2012
Editorial commentJoshua J Meeks
The Journal of Urology|October 23, 2020
Editorial CommentJoshua J Meeks
European Urology|October 10, 2025
"PRIME" Time for Boosting the Immune Response to Bacillus Calmette-GuérinJoshua J Meeks
The Journal of Clinical Investigation|March 2, 2026
The changing landscape of urothelial carcinoma: on the edge of a paradigm shiftJoshua J Meeks
The Journal of Urology|June 19, 2024
Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialJoshua J Meeks
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Analysis of Mutational Signatures Using the mutSignatures R LibraryDamiano Fantini, Joshua J Meeks
Oncoscience|July 24, 2018
The BBN model: a mouse bladder cancer model featuring basal-subtype gene expression and MLL3/MLL4 genetic disruptionDamiano Fantini, Joshua J Meeks
Nature Reviews. Urology|October 17, 2018
T1 bladder cancer: current considerations for diagnosis and managementBrian Jordan, Joshua J Meeks
The Journal of Urology|June 18, 2014
Open conversion during minimally invasive radical prostatectomy: impact on perioperative complications and predictors from national dataVidit Sharma, Joshua J Meeks
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
European Urology Focus|December 5, 2025
Urothelial Cancer: What Is the Role of Expression-based Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive Bladder Cancer?Joshua J Meeks
Urology|April 24, 2012
Editorial commentJoshua J Meeks
The Journal of Urology|October 23, 2020
Editorial CommentJoshua J Meeks
European Urology|October 10, 2025
"PRIME" Time for Boosting the Immune Response to Bacillus Calmette-GuérinJoshua J Meeks
The Journal of Clinical Investigation|March 2, 2026
The changing landscape of urothelial carcinoma: on the edge of a paradigm shiftJoshua J Meeks
The Journal of Urology|June 19, 2024
Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialJoshua J Meeks
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Analysis of Mutational Signatures Using the mutSignatures R LibraryDamiano Fantini, Joshua J Meeks
Oncoscience|July 24, 2018
The BBN model: a mouse bladder cancer model featuring basal-subtype gene expression and MLL3/MLL4 genetic disruptionDamiano Fantini, Joshua J Meeks
Nature Reviews. Urology|October 17, 2018
T1 bladder cancer: current considerations for diagnosis and managementBrian Jordan, Joshua J Meeks
The Journal of Urology|June 18, 2014
Open conversion during minimally invasive radical prostatectomy: impact on perioperative complications and predictors from national dataVidit Sharma, Joshua J Meeks
Pageof 21